Can you take Tums after gastric sleeve surgery? This is a common question among patients recovering from sleeve gastrectomy in the UK, where acid reflux and heartburn are frequent post-operative complaints. While calcium carbonate antacids such as Rennie (the UK equivalent of Tums) are available over the counter and may offer short-term relief, their use after bariatric surgery requires careful consideration. Reduced stomach acid, altered anatomy, drug interactions, and nutrient absorption all play a role in determining whether these preparations are appropriate — and whether a more targeted treatment is needed.

Antacids After Gastric Sleeve Surgery: What You Need to Know

Sleeve gastrectomy alters upper digestive tract anatomy, making careful antacid selection essential; calcium carbonate preparations interact with several key post-operative medicines and should be taken 2–4 hours apart from iron, levothyroxine, and antibiotics.

Gastric sleeve surgery, formally known as sleeve gastrectomy, is one of the most commonly performed bariatric procedures in the UK. It involves removing approximately 75–80% of the stomach, leaving a narrow, tube-shaped pouch. While this significantly reduces food intake and promotes weight loss, it also fundamentally alters the anatomy and physiology of the upper digestive tract — and this has important implications for how you manage symptoms such as heartburn and acid reflux.

Many patients find themselves reaching for over-the-counter calcium carbonate antacids (such as Rennie) in the weeks and months following surgery. This is understandable, as acid-related discomfort is a frequent complaint post-operatively. However, not all antacid preparations are equally appropriate after bariatric surgery, and some may interfere with nutrient absorption or fail to address the underlying cause of your symptoms.

Importantly, calcium carbonate antacids can interact with several other medicines. They should be taken at least 2–4 hours apart from iron supplements, levothyroxine, tetracyclines, quinolone antibiotics, and bisphosphonates, as they can significantly reduce the absorption of these medicines. Always check with your pharmacist or bariatric team before starting any new over-the-counter preparation.

This article provides guidance on managing acid reflux after a sleeve gastrectomy, with reference to UK clinical practice, NHS recommendations, NICE guidance, and specialist bariatric guidance from the British Obesity and Metabolic Surgery Society (BOMSS). Any changes to your medication regimen should be discussed with your bariatric team or GP before being implemented.

Why Acid Reflux Is Common Following a Sleeve Gastrectomy

Acid reflux is more prevalent after sleeve gastrectomy than other bariatric procedures because the smaller tubular stomach generates higher intragastric pressure, and surgery can impair lower oesophageal sphincter function and alter the angle of His.

Acid reflux — also known as gastro-oesophageal reflux disease (GORD) — is notably more prevalent after sleeve gastrectomy compared to other bariatric procedures such as Roux-en-Y gastric bypass. Published systematic reviews and meta-analyses (including Qumseya et al., 2020, and Yeung et al., 2020) suggest that a significant proportion of sleeve patients develop new or worsened GORD symptoms post-operatively, with estimates varying across studies; your bariatric team can advise on your individual risk. In some cases, symptoms can persist long-term.

There are several anatomical and physiological reasons for this:

• Reduced stomach volume and increased intragastric pressure: The smaller, tubular stomach generates higher internal pressure, which can push acidic contents upwards into the oesophagus.

• Altered lower oesophageal sphincter (LOS) function: Surgery near the gastro-oesophageal junction may affect the competence of the LOS, the valve that normally prevents acid reflux.

• Disruption of the angle of His: Removal of the gastric fundus alters the natural anatomical angle that helps prevent reflux.

• Changes in gastric motility: Although the pylorus remains intact, alterations in gastric emptying can contribute to reflux symptoms.

• Hiatus hernia: Pre-existing or newly identified hiatus hernias are a significant risk factor for post-sleeve reflux. Whether repair is undertaken at the time of surgery depends on surgeon assessment, patient factors, and local protocol.

Understanding the underlying mechanism is important because it informs the most appropriate treatment. Simple antacids may offer short-term symptomatic relief, but they do not address the structural or physiological changes driving reflux after a sleeve gastrectomy.

Are Calcium Carbonate Antacids Safe to Take After Bariatric Surgery?

Occasional use of calcium carbonate antacids is not absolutely contraindicated after sleeve gastrectomy, but absorption is reduced when stomach acid is suppressed, and frequent use should prompt a clinical review rather than continued self-management.

Calcium carbonate antacids (such as Rennie) work by neutralising stomach acid on contact, providing relatively rapid but short-lived relief from heartburn and indigestion. In the general population, they are considered safe for occasional use.

After bariatric surgery, however, there are several important considerations:

• Reduced absorption when stomach acid is suppressed: Calcium carbonate requires an acidic environment for adequate absorption. If you are taking a proton pump inhibitor (PPI) — which is common in the post-operative period — absorption of calcium from carbonate-based preparations may be significantly reduced. For this reason, calcium citrate is generally preferred for calcium supplementation in patients on acid-suppressing therapy, as its absorption is not dependent on stomach acid. This is consistent with BOMSS micronutrient supplementation guidance. Discuss the most appropriate form of calcium supplement with your bariatric dietitian.

• Tablet form: Chewable calcium carbonate antacids are generally acceptable post-sleeve, but always confirm with your bariatric team whether a particular preparation is suitable for your stage of recovery.

• Drug interactions: Calcium carbonate antacids can reduce the absorption of iron, levothyroxine, tetracyclines, quinolone antibiotics, and bisphosphonates. Allow at least 2–4 hours between taking these medicines and any calcium-containing antacid.

• Safety and dosing limits: Do not exceed the recommended dose stated on the product packaging. Excessive use can cause constipation, and very high doses over time may rarely lead to hypercalcaemia (raised blood calcium levels). Use with caution if you have kidney disease or a history of kidney stones; seek advice from your GP or pharmacist first.

• Not a treatment for GORD: Calcium carbonate antacids may temporarily ease discomfort, but they do not reduce acid production or address the underlying reflux mechanism. Relying on them as a primary management strategy is not recommended.

There is no absolute contraindication to occasional use of calcium carbonate antacids after a sleeve gastrectomy, but their use should be supplementary rather than routine. If you find yourself needing antacids frequently, this is a signal to seek a formal review from your GP or bariatric team.

If you experience any suspected side effects from any medicine, you can report these via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Medicines Recommended by UK Specialists for Post-Sleeve Reflux

UK bariatric guidelines (BOMSS and NICE CG184) recommend proton pump inhibitors such as omeprazole or lansoprazole as first-line treatment, with many centres routinely prescribing them for 3–6 months post-operatively.

UK bariatric guidelines, including BOMSS guidance on medications after bariatric surgery, and NICE guidance on dyspepsia and GORD (NICE CG184) generally favour proton pump inhibitors (PPIs) as the first-line pharmacological treatment for acid reflux following sleeve gastrectomy. PPIs — such as omeprazole and lansoprazole — work by blocking the proton pump in the stomach lining, significantly reducing acid production.

Key points regarding PPI use after bariatric surgery include:

• Routine post-operative prescribing: Many UK bariatric centres, in line with BOMSS guidance, routinely prescribe a PPI for the first 3–6 months following sleeve gastrectomy to protect the gastric mucosa and reduce reflux symptoms during the healing period. This reflects common local practice; your own bariatric team will advise on the duration appropriate for you. A typical starting dose is omeprazole 20 mg once daily, which may be stepped up to twice daily if symptoms are not adequately controlled.

• Liquid or dispersible formulations: In the early post-operative weeks, liquid or orodispersible PPI formulations (such as lansoprazole orodispersible tablets) are recommended to aid swallowing and absorption, as standard tablets may be difficult to tolerate. Modified-release capsules should generally be avoided in the early post-operative period unless advised otherwise by your bariatric team. Follow your local bariatric protocol and refer to the relevant Summary of Product Characteristics (SmPC) for the specific formulation prescribed.

• Long-term use and review: For patients with persistent GORD, long-term PPI therapy may be appropriate. In line with NICE CG184, PPIs should be reviewed regularly and stepped down to the lowest effective dose. Long-term use carries potential risks (including effects on magnesium and vitamin B12 levels) and should be monitored by your GP.

H2 receptor antagonists (such as famotidine) are an alternative for patients who cannot tolerate PPIs, though they are generally considered less effective for sustained acid suppression.

Alginate-based preparations (such as Gaviscon Advance) can be a useful adjunct, forming a physical 'raft' on top of stomach contents to reduce reflux episodes. These are widely used in UK clinical practice and are available over the counter. Always check with your pharmacist or bariatric team before starting any new medication, and refer to the product SmPC for dosing and safety information.

When to Seek Advice From Your Bariatric Team

Persistent heartburn despite prescribed medication, dysphagia, regurgitation, or signs of GI bleeding require prompt review; vomiting blood, black stools, or severe chest pain require immediate emergency care via 999.

Not sure if this is normal? Chat with one of our pharmacists →

Mild, intermittent heartburn in the early weeks after sleeve gastrectomy is common and often manageable with dietary adjustments and prescribed medication. However, there are specific symptoms and circumstances that warrant prompt review by your bariatric team or GP.

Contact your bariatric team or GP promptly if you experience:

• Persistent or worsening heartburn despite taking prescribed acid-suppressing medication

• Difficulty swallowing (dysphagia) or a sensation of food sticking in the chest or throat

• Regurgitation of undigested food or bile

• Persistent nausea or vomiting, or an inability to keep fluids down

• Unexplained or unintentional weight loss

• Signs of anaemia or nutritional deficiency, such as fatigue, hair loss, or tingling in the extremities

Seek urgent medical attention (call 999 or go to your nearest A&E) if you experience:

• Vomiting blood or material that looks like coffee grounds (haematemesis)

• Black, tarry, or bloody stools (melaena) — these may indicate gastrointestinal bleeding

• Severe chest pain — to rule out cardiac causes

• Severe epigastric pain with fever

For chest pain or suspected GI bleeding, call 999 immediately. For other urgent concerns outside of normal hours, contact NHS 111.

Alarm features such as progressive dysphagia, unexplained weight loss, or signs of GI bleeding should prompt urgent assessment and may require referral for endoscopy in line with NICE guidance (NICE CG184; NICE NG12 on suspected cancer: recognition and referral).

It is also worth noting that persistent, severe GORD following sleeve gastrectomy may, in some cases, indicate the need for revisional surgery — most commonly conversion to a Roux-en-Y gastric bypass, which is associated with significantly lower rates of reflux. This decision would be made by your bariatric multidisciplinary team following thorough investigation, which may include endoscopy, pH monitoring, or oesophageal manometry.

Finally, do not underestimate the role of lifestyle measures. Eating slowly, avoiding lying down within two to three hours of meals, reducing caffeine and carbonated drinks, and maintaining a healthy post-operative weight can all contribute meaningfully to symptom control. Your bariatric dietitian is an invaluable resource in tailoring these recommendations to your individual needs and stage of recovery.

Frequently Asked Questions